Background: Charcot-Marie-Tooth type 1A (CMT1A) is the most common type of hereditary motor and sensory neuropathies (HMSN), caused by the duplication of the 17p11.2 region that includes the PMP22 gene. Reciprocal deletion of the same region is the main cause of hereditary neuropathy with liability to pressure palsies (HNPP). CMT1A accounts for approximately 50% of HMSN patients. Diagnostics of CMT1A and HNPP are based on quantitative analysis of the affected region or RFLP detection of breakage points. The aim of this study was to improve the sensitivity and efficiency of CMT1A and HNPP genetic diagnostics by introducing analysis of six STR markers (D17S261-D17S122-D17S839-D17S1358-D17S955-D17S921) spanning the duplicated region.
Methods: Forty-six CMT1A and seven HNPP patients, all genetically diagnosed by RFLP analysis, were tested for duplication or deletion using six STR markers.
Results: In all CMT1A and HNPP patients, microsatellite analysis comprising six STR markers confirmed the existence of a duplication or deletion. In 89% (41/46) CMT1A patients the confirmation was based on detecting three alleles on at least one locus. In the remaining 11% (5) CMT1A patients, duplication was also confirmed based on two peaks with clear dosage difference for at least two different markers. All HNPP patients (7/7) displayed only one allele for each analyzed locus.
Conclusions: Microsatellite analysis using six selected STR loci showed a high level of sensitivity and specificity for genetic diagnostics of CMT1A and HNPP. The results here strongly suggest STR marker analysis as a method of choice in PMP22 duplication/deletion testing.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1515/cclm-2015-0602 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Loss of YAP in Schwann cells improves HNPP pathophysiology.
Glia
November 2024
Department of Biochemistry, University at Buffalo, Buffalo, New York, USA.
Rapid nerve conduction in the peripheral nervous system (PNS) is facilitated by the multilamellar myelin sheath encasing many axons of peripheral nerves. Charcot-Marie-Tooth type 1A (CMT1A), and hereditary neuropathy with liability to pressure palsy (HNPP) are common demyelinating inherited peripheral neuropathies and are caused by mutations in the peripheral myelin protein 22 (PMP22) gene. Duplication of PMP22 leads to its overexpression and causes CMT1A, while its deletion results in PMP22 under expression and causes HNPP.
View Article and Find Full Text PDFWhole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease.
Brain
September 2024
Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Article Synopsis
- Charcot-Marie-Tooth disease (CMT) is a common inherited neurological disorder with over 130 genes linked to it, and whole genome sequencing (WGS) has enhanced diagnosis but its full impact on CMT is still being evaluated.
- In a study at a specialist inherited neuropathy center from 2009 to 2023, 1515 patients were assessed, revealing that genetic diagnoses were achieved in 76.9% of cases, particularly high in CMT1 at 96.8%.
- The most frequent genetic cause was PMP22 duplication (CMT1A), accounting for 43.3% of diagnoses, and a subset of 233 cases were included in the UK 100,000 Genomes
Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseases.
EMBO Mol Med
March 2024
Research Group "Translational Neurogenetics", Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Haplo-insufficiency of the gene encoding the myelin protein PMP22 leads to focal myelin overgrowth in the peripheral nervous system and hereditary neuropathy with liability to pressure palsies (HNPP). Conversely, duplication of PMP22 causes Charcot-Marie-Tooth disease type 1A (CMT1A), characterized by hypomyelination of medium to large caliber axons. The molecular mechanisms of abnormal myelin growth regulation by PMP22 have remained obscure.
View Article and Find Full Text PDFNoncanonical splice-site variant in peripheral myelin protein 22 gene (PMP22) in a patient with hereditary neuropathy with liability to pressure palsies.
J Peripher Nerv Syst
September 2023
Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Aim: Hereditary neuropathy with liability to pressure palsies (HNPP) is a peripheral neuropathy with autosomal dominant inheritance. Diagnosis can be made from the characteristic abnormalities determined by nerve conduction studies (NCS), including subclinical deficits at physiological compression sites. Heterozygous deletion of the chromosome 17p11.
View Article and Find Full Text PDFUtility of Carpal Tunnel Release and Ulnar Decompression in CMT1A and HNPP.
Muscle Nerve
October 2022
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Introduction/aims: Carpal and cubital tunnel syndrome (CTS, CuTS) are common among patients with hereditary neuropathy with liability to pressure-palsies (HNPP) and Charcot-Marie-Tooth type 1A (CMT1A) and may impact quality of life. We aimed to evaluate the utility of nerve decompression surgeries in these patients.
Methods: Medical records were reviewed for patients with PMP22 mutations confirmed in Mayo Clinic laboratories from January 1999 to December 2020, who had CTS and CuTS and underwent surgical decompression.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!